Literature DB >> 8920849

Mechanisms of cytokine-mediated localized immunoprotection.

N Sarvetnick1.   

Abstract

Mesh:

Substances:

Year:  1996        PMID: 8920849      PMCID: PMC2192879          DOI: 10.1084/jem.184.5.1597

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


× No keyword cloud information.
  22 in total

1.  Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma.

Authors:  N Sarvetnick; J Shizuru; D Liggitt; L Martin; B McIntyre; A Gregory; T Parslow; T Stewart
Journal:  Nature       Date:  1990-08-30       Impact factor: 49.962

2.  Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1.

Authors:  C O Jacob; S Aiso; S A Michie; H O McDevitt; H Acha-Orbea
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

3.  Antigen-presenting cells in adoptively transferred and spontaneous autoimmune diabetes.

Authors:  D Lo; C R Reilly; B Scott; R Liblau; H O McDevitt; L C Burkly
Journal:  Eur J Immunol       Date:  1993-07       Impact factor: 5.532

4.  Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice.

Authors:  D E Picarella; A Kratz; C B Li; N H Ruddle; R A Flavell
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

5.  Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse.

Authors:  K J Pennline; E Roque-Gaffney; M Monahan
Journal:  Clin Immunol Immunopathol       Date:  1994-05

6.  Tumor antigen presentation by epidermal antigen-presenting cells in the mouse: modulation by granulocyte-macrophage colony-stimulating factor, tumor necrosis factor alpha, and ultraviolet radiation.

Authors:  S Grabbe; S Bruvers; A M Lindgren; J Hosoi; K C Tan; R D Granstein
Journal:  J Leukoc Biol       Date:  1992-08       Impact factor: 4.962

7.  Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes.

Authors:  Y Higuchi; P Herrera; P Muniesa; J Huarte; D Belin; P Ohashi; P Aichele; L Orci; J D Vassalli; P Vassalli
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

8.  Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans.

Authors:  L Wogensen; X Huang; N Sarvetnick
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

9.  Tumor necrosis factor alpha/cachectin is a growth factor for thymocytes. Synergistic interactions with other cytokines.

Authors:  G E Ranges; A Zlotnik; T Espevik; C A Dinarello; A Cerami; M A Palladino
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

10.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.

Authors:  F Sallusto; A Lanzavecchia
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  3 in total

1.  Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy.

Authors:  K Akassoglou; J Bauer; G Kassiotis; M Pasparakis; H Lassmann; G Kollias; L Probert
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

2.  T cell receptor signaling induced by an analog peptide of type II collagen requires activation of Syk.

Authors:  Bo Tang; Jing Zhou; Jeoung-Eun Park; David Cullins; Ae-Kyung Yi; Andrew H Kang; John M Stuart; Linda K Myers
Journal:  Clin Immunol       Date:  2009-10       Impact factor: 3.969

3.  Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis.

Authors:  J P Seery; J M Carroll; V Cattell; F M Watt
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.